未登录

S

Shukai Yuan

Tianjin Medical University

H指数:11

被引数:720

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

USP9X integrates TGF-β and hypoxia signalings to promote ovarian cancer chemoresistance via HIF-2α-maintained stemness

USP9X通过HIF-2α维持的干性，整合TGF-β和缺氧信号通路以促进卵巢癌的化疗耐药性。

CELL DEATH & DISEASE

IF9.6

2025-04-181

OA

Targeting miR-31 represses tumourigenesis and dedifferentiation of BRAFV600E-associated thyroid carcinoma

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2024-05-261

OAAI

miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma

IF7.3

2023-11-170

OAAI

miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma

IF2.9

2023-07-194

PRE

Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors (vol 13, 1588, 2022)

NATURE COMMUNICATIONS

IF15.7

2022-11-171

OAAI

Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors

NATURE COMMUNICATIONS

IF15.7

2022-03-2446

OAAI

miR-22 promotes stem cell traits via activating Wnt/beta-catenin signaling in cutaneous squamous cell carcinoma (vol 40, pg 5799, 2021)

IF7.3

2022-02-040

OAAI

miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma

IF7.3

2021-08-0326

OAAI

Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway

IF7.3

2021-06-2119

PREAI

MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists (vol 8, 1036, 2017)

NATURE COMMUNICATIONS

IF15.7

2020-10-153

OAAI

MiR-31 Mediates Inflammatory Signaling to Promote Re-Epithelialization during Skin Wound Healing

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2018-10-0190

OAAI

TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57KIP2 repression

IF7.3

2018-03-0724

PREAI

MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists

NATURE COMMUNICATIONS

IF15.7

2017-10-19160

OAAI

Antitumor activity and safety of pembrolizumab in patients with PD-L1-positive nasopharyngeal carcinoma: Interim results from a phase 1b study

EUROPEAN JOURNAL OF CANCER

IF7.1

2015-09-016

PREAI

Pembrolizumab (MK-3475) for PD-L1-positive squamous cell carcinoma (SCC) of the anal canal: Preliminary safety and efficacy results from KEYNOTE-028

EUROPEAN JOURNAL OF CANCER

IF7.1

2015-09-016

PREAI

Pembrolizumab (MK-3475) for patients (pts) with advanced colorectal carcinoma (CRC): Preliminary results from KEYNOTE-028

EUROPEAN JOURNAL OF CANCER

IF7.1

2015-09-0114

PREAI